Previous PageTable Of ContentsNext Page

Annex 1: Summary of All HIV/AIDS Indicators


Behaviour Change Communication (BCC)

Condom promotion and distribution

Blood safety

Management of sexually transmitted infections (STIs)

HIV counseling and testing

Prevention of mother-to-child transmission (PMTCT)

Universal precautions (UP) and post-exposure prophylaxis (PEP)

Service availability

Socioeconomic and material support

Clinical care including ARV therapy and TB treatment

Orphans and vulnerable children (OVC)

Legal and human rights

Mainstreaming

Surveillance and research

National commitment and action

Monitoring and evaluation

Capacity Building

Financial utilization

Download the full document (pdf format )


Impact

 

Imp1

Percentage of pregnant women aged 15-49 years attending ANC clinics who are HIV infected (disaggregated by age, region and urban/rural)

Behaviour Change Communication (BCC)

Prv1

Percentage of people aged 15-49 years who both correctly identify ways of preventing the sexual transmission of HIV and who reject major misconceptions about HIV transmission (disaggregated by age, sex, target population, region and urban/rural)

Prv2

Median age at first sex (disaggregated by age, sex, region and urban/rural)

Prv3

Number of teachers trained in life-skills-based HIV/AIDS education and graduated in the last 12 months

Prv4

Percentage of people aged 15-49 years reporting the use of a condom during last sexual intercourse with a non-regular sexual partner (disaggregated by age, sex, target population, region and urban/rural)

Prv5

Percentage of people aged 15-49 years expressing accepting attitudes towards people with HIV/AIDS (disaggregated by age, sex, target population, region and urban/rural)

Condom promotion and distribution

Prv4

Percentage of people aged 15-49 years reporting the use of a condom during last sexual intercourse with a non-regular sexual partner (disaggregated by age, sex, target population, region and urban/rural) [Also used for BCC]

Prv6

Percent of condoms imported that meet the national quality standard

Prv7

Total number of condoms available for distribution nationwide during the preceding 12 months, divided by the total population aged 15-49 (disaggregated by male/female condoms)

Prv8

The proportion of randomly selected retail outlets and service delivery points that have condoms in stock at the time of a survey (disaggregated by region and urban/rural)

Blood safety

Prv9

Percentage of voluntary, non-remunerated blood donors donating blood in the last 12 months (disaggregated by age, sex and urban/rural)

Prv10

Number of blood units collected in the last 12 months (disaggregated by region and urban/rural)

Prv11

Number of blood banks in the country (disaggregated by region and urban/rural)

Management of sexually transmitted infections (STIs)

Prv12

Percentage of people aged 15-49 years who know two or more symptoms of STIs (disaggregated by age, sex, target population region and urban/rural)

Prv13

Percentage of patients with STIs at health-care facilities who are appropriately diagnosed, treated and counseled (disaggregated by age, sex, region and urban/rural)

Prv14

Percent of health facilities providing STI care that have a current supply of essential STI drugs and report no stock out lasting longer than one week in the preceding 12 months (disaggregated by region)

Prv15

Number of health workers trained in syndromic management of STIs according to national guideline in the last 12 months (disaggregated by region)

HIV counseling and testing

Prv16

Number of individuals receiving HIV counseling and testing in the last 12 months:

    (a) Number of individuals who received pre-test counselling,

    (b) Percent of those counselled who received HIV testing,

    (c) Percent of those tested who were positive,

    (d) Percent of those tested who received their results through post-test counselling services, and

    (e) Percent of those tested HIV-positive who were referred to care and support services

    (disaggregated by type of service (voluntary/diagnostic), age, sex, region and urban/rural)

Prevention of mother-to-child transmission (PMTCT)

Prv17

Percentage of HIV-infected pregnant women receiving a complete course of antiretroviral prophylaxis to reduce the risk of MTCT in accordance with nationally approved treatment protocol in the last 12 months (disaggregated by region)

Prv18

Percentage of HIV-infected infants born to HIV-infected mothers (disaggregated by region)

Prv19

Percentage of all possible public, private, missionary and workplace health facilities (family planning and primary health care clinics, ANC/MCH, and maternity hospitals) providing the minimum package of services to prevent HIV infection in women and infants in the past 12 months (disaggregated by region)

Prv20

Percentage of pregnant women that:

    a. Attend at least one ANC visit

    b. Attend at least one ANC visit that is a PMTCT site

    c. Receive pre-test counseling on HIV

    d. Receive testing for HIV

    e. Receive post-test counseling on HIV

    f. Receive HIV results

Prv21

Number of health facilities providing PMTCT services in the past 12 months (disaggregated by region)

Universal precautions (UP) and post-exposure prophylaxis (PEP)

Prv22

Percentage of health facilities that have guidelines to prevent nosocomial transmission of HIV, adequate sterilization procedures, and protective materials and equipment such as syringes, gloves and antiseptics in stock at the time of the survey (disaggregated by region)

Service availability

Prv23

Percentage of Woredas with at least one VCT center in the last 12 months (disaggregated by region)

Prv24

Percentage of Woredas with at least one health facility providing PMTCT (disaggregated by region)

Prv25

Percentage of Woredas with at leas one health facility providing ART (disaggregated by region)

Prv26

Number of Regions/Woredas who have established HIV/AIDS resource center

Socioeconomic and material support

CST1

Percentage of people aged 15-59 who has been ill for 3 or more months in the last 12 months and whose household received free basic external support in caring for the chronically ill person (disaggregated by age, sex, region and source, type and level of free support)

CST2

Number of people aged 15-59 who has received help from home-based program in the last 12 months (disaggregated age, sex, region and type and level of support)

Clinical care including ARV therapy and TB treatment

CST3

Percentage of people with advanced HIV infection receiving ARV combination therapy (disaggregated by age, sex, region, and urban/rural)

CST4

Percentage of health facilities that either provide comprehensive care and support services onsite for people living with HIV/AIDS or through an effective referral system (disaggregated by region)

CST5

Percentage of health facilities that have the capacity and conditions to provide basic level HIV testing and HIV/AIDS clinical management (disaggregated by region)

CST6

Percentage of health facilities that have the capacity and conditions to provide advanced level HIV care and support services, including provision and monitoring of ART (disaggregated by region)

CST7

Percentage of designated laboratories with the capacity to monitor ART according to national guidelines

Orphans and vulnerable children (OVC)

CST8

Percentage of households caring for orphans and vulnerable children who received free external support in the last 12 months (disaggregated by age and sex of OVC, region and source, type and level of free support)

CST9

Number of orphans and vulnerable children who received free external support in the last 12 months (disaggregated by age and sex of OVC, region and type and level of free support)

CST10

Ratio of current school attendance among orphans to that among non-orphans aged 10-14 (disaggregated by age, sex, region and urban/rural)

Legal and human rights

CST11

National policy index on human rights

    · Country has laws and regulations that protect against discrimination of people living with HIV/AIDS

    · Country has laws and regulations that protect against discrimination of groups of people identified as being especially vulnerable to HIV/AIDS

    · Country has a policy to ensure equal access for men and women to prevention and care, with emphasis on vulnerable groups

    · Country has a policy to ensure that HIV/AIDS research protocols involving human subjects are reviewed and approved by an ethics committee (at the Science and Technology Commission of Ethiopia)

CST12

Percentage of PLWHA who correctly know their rights and obligations under the law (disaggregated by age, sex and region)

CST13

Percentage of HIV/AIDS related court cases in the last 12 months that were settled in the same period

Mainstreaming

PS1

Percentage of large enterprises/companies that have HIV/AIDS workplace policies and programs

PS2

Percentage of government offices that have integrated specific HIV/AIDS activities into their sector plan in the last 12 months

Surveillance and research

PS3

Number of national level HIV/AIDS related researches carried out in the last 12 months

PS4

Number of National HIV sentinel surveillance sites existing at the time of data collection (disaggregate by region and urban/rural)

National commitment and action

PS5

Amount of National funds spent by the Government on HIV/AIDS

PS6

National composite policy index

PS7

Existence of policies, strategies, guidelines and frameworks produced at national level

PS8

Operationalization (at all levels) of policies, strategies, guidelines and frameworks produced at national level

Monitoring and evaluation

PS9

Percentage spending for M&E by HAPCO in the last 12 months

PS10

Proportion of all stakeholders implementing/supporting HIV/AIDS projects/programs that submit timely reports to HAPCO using standard reporting formats

 

Capacity Building

PS11

Number of National Partnership Forum and Joint Review meetings organized by HAPCO in the last 12 months

PS12

Number of Regional HAPCOs that have installed CRIS and established an online access with National HAPCO

PS13

Number of staff at Regional and Woreda level trained on M&E and Project Management by HAPCO in the last 12 months

Financial utilization

PS14

Financial allocation and utilization in the last 12 months (disaggregated by component: BCC, Condom promotion and distribution, etc.)



Previous PageTop Of PageNext Page